September 2022 Research Summary:
Clinical Outcomes and Cost Associated With an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump in Patients Presenting With Acute Myocardial Infarction Complicated by Cardiogenic Shock
A propensity-matched analysis underscores the need for optimal management of patients undergoing PCI for a heart attack or acute myocardial infarction.
Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure
The REVeAL-HF (Risk Evaluation and its Impact on Clinical Decision Making and Outcomes in Heart Failure) trial assessed whether provision of mortality estimates impacted clinical decision-making and outcomes in hospitalized patients with heart failure. The results appear in JAMA Cardiology.
The Impact of COVID-19 on Physician Scientist Trainees and Faculty in the United States: A National Survey
With the support of the American Physician Scientists Association (APSA), researchers conducted a national survey of more than 2,000 physician-scientist trainees and faculty.
Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis
In this systematic review and meta-analysis, researchers investigated the effects of using DAPT for 1 to 3 months compared with 6 to 12 months to prevent ischemia.
Featured in this article
- Eric Velazquez, MDRobert W. Berliner Professor of Medicine (Cardiology); Chief, Cardiovascular Medicine; Chief, Cardiovascular Medicine, Yale New Haven Hospital; Physician-in-Chief, Heart and Vascular Center, Yale New Haven Health; Deputy Director, Clinical Trials Innovation, Yale Center for Clinical Investigation (YCCI); Co-Chair, Clinical and Translational Research Oversight Committee; President’s contingency planning committee, Clinical Practice/Clinical Research Subcommittee